LDHC4 promotes ovarian cancer progression through H4K12 lactylation to regulate PGK1 expression and modulate glycolysis

糖酵解 卵巢癌 癌症研究 生物 医学 化学 基因表达 癌症 酶 细胞生物学 新陈代谢 卵巢 碳水化合物代谢 基因表达调控 内科学 癌细胞 生物信息学 细胞培养
作者
Yingying Lin,Yanping Xiao,Lingqing Luo,Lingjing Lin,Lin Zhi,Cheng Sun,Zhaolei Cui
出处
期刊:Journal of Translational Medicine [BioMed Central]
卷期号:24 (1): 351- 被引量:4
标识
DOI:10.1186/s12967-026-07695-0
摘要

OBJECTIVE: Ovarian cancer (OC) pathogenesis involves metabolic and epigenetic alterations, yet the underlying mechanisms remain unclear. Here, we sought to investigate the role and regulatory mechanism of lactate dehydrogenase C4 (LDHC4) in OC progression. METHODS: Multi-omics approaches were employed, including analyses of The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) cohorts, tissue microarrays, molecular biology experiments, and in vivo mouse models. LDHC4 expression was modulated in OC cell lines (A2780 and ES-2) to assess its effects on proliferation, migration, invasion, and metastasis. Lactylproteomic profiling, cleavage under targets and tagmentation (CUT&Tag), and chromatin analyses were conducted to explore epigenetic mechanisms. The functional role of the downstream glycolytic enzyme phosphoglycerate kinase 1 (PGK1) was examined using pharmacological inhibition. Molecular docking and xenograft models were used to evaluate the therapeutic potential of targeting H4K12lac (lactylation of histone H4 at lysine 12). RESULTS: LDHC4 was significantly overexpressed in OC tissues and associated with poor overall survival (OS) (hazard ratio [HR] = 4.017, 95% confidence interval [CI]: 2.308–6.989, P < 0.0001). It promoted proliferation, migration, invasion, and metastasis in vitro and in vivo. LDHC4 overexpression increased global lactylation, notably upregulating H4K12lac, which was enriched at the PGK1 promoter. Inhibition of PGK1 with CBR-470-1 (half-maximal inhibitory concentration [IC₅₀] = 14.56 µM) suppressed OC growth and metastasis. Importantly, Elbasvir, identified as a high-affinity H4K12lac inhibitor, significantly reduced tumor burden in mouse xenografts across multiple doses (10–20 mg·kg⁻¹) and downregulated H4K12lac and Ki-67 expression. CONCLUSION: We conclude that LDHC4 promotes OC progression via lactylation-mediated epigenetic upregulation of PGK1. Targeting this pathway through H4K12lac inhibitors such as Elbasvir thus emerges as a viable therapeutic approach for OC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
www完成签到,获得积分10
1秒前
1秒前
momo完成签到,获得积分10
2秒前
研友_VZG7GZ的应助被明智小聪采纳,获得30
2秒前
STAR完成签到,获得积分10
3秒前
xiaoming发布了新的文献求助10
3秒前
斯文败类的应助被123采纳,获得10
3秒前
4秒前
4秒前
5秒前
liaoxinghui发布了新的文献求助10
5秒前
FashionBoy的应助被LSF采纳,获得10
5秒前
陈辉辉发布了新的文献求助10
5秒前
嘻嘻哈哈的应助被辛勤绾绾采纳,获得10
6秒前
7秒前
研友_8yNO0L发布了新的文献求助10
7秒前
STAR发布了新的文献求助10
7秒前
自然的以亦完成签到,获得积分10
8秒前
江澄子给江澄子的求助进行了留言
8秒前
Cherdong完成签到,获得积分10
9秒前
9秒前
哈斯u和发布了新的文献求助10
9秒前
9秒前
10秒前
于庭完成签到,获得积分10
10秒前
英俊的铭的应助被龚龚龚采纳,获得10
10秒前
woya发布了新的文献求助10
10秒前
学习的小饭完成签到 ,获得积分10
10秒前
Jinagu发布了新的文献求助10
10秒前
10秒前
干净涵梅的应助被宋硕asad采纳,获得80
11秒前
Cker完成签到,获得积分10
11秒前
blzzue_发布了新的文献求助10
11秒前
Skyline完成签到,获得积分10
11秒前
11秒前
11秒前
13秒前
Doctorye完成签到,获得积分10
13秒前
咕_完成签到 ,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191868
求助须知:如何正确求助?哪些是违规求助? 9578583
关于积分的说明 21860514
捐赠科研通 7791338
什么是DOI,文献DOI怎么找? 3436743
关于科研通互助平台的介绍 2560477
邀请新用户注册赠送积分活动 2483527